| | % | % 5 Tage | % 1. Jan. | Veränd. 1 J. | Veränd. 3 J. | Wert (M$) |
 | BRISTOL-MYERS SQUIBB COMPANY | -0.13% | 0.24% | 20.06% | 11.10% | 60.95% | 160 059 |
| | | | | | | |
| JOHNSON & JOHNSON | 0.29% | -1.58% | -0.23% | -1.78% | 29.36% | 447 434 |
| ELI LILLY AND COMPANY | 0.52% | -5.37% | 10.28% | 13.05% | 168.14% | 287 922 |
| PFIZER, INC. | 0.34% | -2.05% | -15.41% | 3.65% | 41.14% | 279 310 |
 | ROCHE HOLDING AG | -0.44% | 0.20% | -16.39% | -12.53% | 16.48% | 275 991 |
| ABBVIE INC. | 0.49% | -0.10% | 4.09% | 22.75% | 118.41% | 247 976 |
 | NOVO NORDISK A/S | 2.01% | -9.96% | 6.37% | 22.77% | 134.07% | 238 658 |
| MERCK & CO., INC. | -0.37% | 2.18% | 16.38% | 18.62% | 4.04% | 226 779 |
 | ASTRAZENECA PLC | -0.22% | 0.58% | 24.66% | 32.01% | 47.16% | 203 058 |
| NOVARTIS AG | -0.90% | 1.86% | 2.78% | -2.53% | -6.49% | 190 668 |
| AMGEN INC. | 1.50% | 1.82% | 12.05% | 10.59% | 22.50% | 132 855 |
 | SANOFI | -8.18% | -1.52% | -1.03% | 0.71% | 18.87% | 122 268 |
| GSK PLC | -5.48% | -2.84% | -22.49% | -14.02% | -25.42% | 80 582 |
 | BAYER AG | -0.50% | -10.07% | 10.43% | 9.95% | -19.70% | 52 412 |
 | DAIICHI SANKYO CO., LTD. | 0.86% | 10.73% | 24.17% | 82.56% | 57.23% | 51 146 |
| CHUGAI PHARMACEUTICAL CO., LTD | 0.03% | 4.76% | 1.31% | -5.42% | 51.16% | 46 111 |
| | | | | | | |
| | Durchschnitt | -0.67% | -0.76% | 3.80% | 12.02% | 43.80% | |
| | Gewichteter Durchschnitt nach Marktkapitalisierung | -0.23% | -1.44% | 2.54% | 9.26% | 54.01% | |
English (USA)
English (UK)
English (Canada)
Deutsch (Schweiz)
Español
Français (France)
Italiano
Nederlands (Nederland)
Nederlands (België)
Bericht
